Access to HIV prevention and opioid use disorder treatment for people who inject drugs

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CHORUS+ initiative aims to improve the uptake and adherence to HIV pre-exposure prophylaxis (PrEP) and the continuation of medication for opioid use disorder (MOUD) among individuals who inject opioids. This intervention utilizes a peer-delivered, mobile phone-supported approach that includes HIV self-testing and rapid initiation of PrEP. By addressing the barriers to accessing these critical health services, the study seeks to enhance health outcomes for this vulnerable population. Participants will be recruited from the Boston area and will receive support through motivational interviewing and peer recovery coaching.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Injected opioids within the past 6 months (by self-report)
* Willingness to provide contact information for two family members or friends
* Willingness to sign medical records release forms
* Ability to speak English
* Plans to reside in Boston area for the next 6 months
* Are medically cleared to take PrEP and MOUD (normal renal and PrEP-related labs)

Exclusion Criteria:

* Persons with previous HIV diagnosis (by self-report; confirmed via HIV test result)
* Express desire to harm themselves or others
* Individuals who are pregnant at baseline
* Individuals who are already enrolled in an interventional study

Where it's running

• Boston Medical Center Faster Paths Bridge Clinic
  Boston, Massachusetts, United States Recruiting
• Victory Programs Mobile Prevention Services Van and Navigation Center
  Boston, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Sabrina A Assoumou, MD MPH — Boston Medical Center, Infectious Diseases
• Study coordinator: Sabrina A Assoumou, MD MPH
• Email: sabrina.assoumou@bmc.org
• Phone: 617-414-2857

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CBD for Opioid Dependence and Pain on Buprenorphine

  This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.

  Recruiting Early Phase 1 Yale University · West Haven, Connecticut · NCT07886606

• Cebranopadol for opioid withdrawal in adults with chronic pain

  This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.

  Recruiting at 2 sites Phase 2 Adneuris Therapeutics, Inc. · North Canton, Ohio and 1 other locations · NCT07874620

• emPath platform pilot to link and keep adults with opioid use disorder in care in Durham

  This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.

  Recruiting Duke University · Durham, North Carolina · NCT07810322

• CB1 Receptors in Opioid Use Disorder Measured with a PET Radioligand

  This study tests CB1 receptor availability in people with opioid use disorder starting opioid agonist therapy and compares them with healthy adults.

  Recruiting Phase 1 Yale University · New Haven, Connecticut · NCT07800520

• STORC: Training a support person plus patient navigation after birth

  We’re testing whether training a designated support person and using patient navigation after delivery helps people with opioid use disorder build recovery resources and stay in treatment.

  Recruiting Friends Research Institute, Inc. · Philadelphia, Pennsylvania · NCT07787039

• Personalized Addiction Treatment Enhancement for Opioid Use Disorder

  A digital platform run by peer recovery supporters will be tested to help adults with opioid use disorder who are on buprenorphine or methadone stay in treatment and improve outcomes.

  Recruiting Rhode Island Hospital · Providence, Rhode Island · NCT07778394

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.